Jula Inrig, Chief Medical Officer: Travere Therapeutics TVTX Planned sale · Filed 02/04

Trade details

Type: Planned sale notice
Stock: Travere Therapeutics TVTX
Person: Jula InrigChief Medical Officer
Planned sale date: 26/02/04
Filed: 26/02/04

More to sell after $951.8K in 3 months

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 01/05~03/06

Jula Inrig's recent trades

Jula InrigChief Medical Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$2.9M
44,674 sh
$2.9M
Filed 09/15
Traded 09/15
Jula InrigChief Medical Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$900K
20,000 sh
$900K
Filed 05/06
Traded 05/04
Jula InrigChief Medical Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$101.4K
2,174 sh
$101.4K
Filed 05/06
Traded 05/05
Jula InrigChief Medical Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$13.7K
311 sh
$13.7K
Filed 05/06
Traded 05/06
Jula InrigChief Medical Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$13.7K
311 sh
$13.7K
Filed 05/06
Traded 05/06

Jula Inrig, Chief Officer — plans to sell 1,779 sh of Travere Therapeutics TVTX · $57.3K · around 02/04 · 10b5-1 plan | Whalegun